<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mane, ‪Shivshankar R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Advances of hydrazone linker in polymeric drug delivery</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Critical Reviews</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">FEB</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">6</style></volume><pages><style face="normal" font="default" size="100%">1-4</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Polymeric drug delivery vehicles are known for the controlled release of the drug. More importantly, stimuli-responsive systems are emerged as a suitable platform for targeted drug delivery system, due to its properties such as low toxicity, improved patient compliance, and convenience. In the present article, an overview of the hydrazone linker used in drug delivery is discussed. Particularly, the role of hydrazone linker in anti-cancer drug delivery system is elaborated, as the hydrazone linker gets cleaved under cancerous cell environment at pH 5.</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><custom3><style face="normal" font="default" size="100%">Foreign</style></custom3><custom4><style face="normal" font="default" size="100%">0.54</style></custom4></record></records></xml>